Convertible Note Prospectus
| Stock | Osteopore Ltd (OSX.ASX) |
|---|---|
| Release Time | 28 Mar 2025, 4:44 p.m. |
| Price Sensitive | Yes |
Osteopore Ltd Announces Convertible Note Prospectus
- Offer of 20 Convertible Notes with a face value of $50,000 each
- Issued under a $20 million subscription agreement with Advance Opportunities Fund
- Convertible Notes to be issued to sophisticated investor Advance Opportunities
Osteopore Ltd has released a prospectus for the offer of 20 convertible notes with a face value of $50,000 each, for an aggregate subscription amount of up to $1,000,000. This offer is part of a $20 million subscription agreement the company entered into with Advance Opportunities Fund and Advance Opportunities Fund I, Cayman Islands-based investment funds, in December 2024. Under the agreement, the funds have already subscribed for and the company has issued 40 convertible notes for an aggregate nominal amount of $2,000,000. The company and the funds have now agreed to a subsequent investment of $1,000,000, for which this prospectus has been issued. The key terms and conditions of the convertible notes are detailed in the prospectus. The offer will only be extended to Advance Opportunities, which is a sophisticated investor and does not ordinarily require a disclosure document under the Corporations Act to subscribe for the securities. The purpose of the prospectus is to ensure the on-sale of the securities does not breach the Corporations Act. There is no minimum subscription, and no oversubscriptions will be accepted. The offer is not underwritten, and the convertible notes will not be quoted on the ASX.